EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Valsartan Mitigates the Progression of Methotrexate-Induced Acute Kidney Injury in Rats via the Attenuation of Renal Inflammation and Oxidative Stress

Dina Kutbi, Riyadh S Almalki iD

Journal of Inflammation Research · 2024-04 · Volume 17 · 2233-2243

DOI: 10.2147/jir.s456610 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inflammation Research, 2024-04. Verfasst von Dina Kutbi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Methotrexate (MTX) is a folic acid antagonist, commonly administered for the treatment of a variety of cancers. However, methotrexate toxicity including bone marrow suppression and hepatic and renal toxicity limits its use. Angiotensin AT1 receptor blockers including Valsartan (Val) possess the ability to ameliorate MTX-induced toxicity through various mechanisms. In this study, we explored the potential reno-protective effects of Val against MTX-induced acute kidney injury in rats.

Methods

Twenty-four Wistar rats were randomly segregated into 3 groups. Group 1 served as the control group and received an oral dose of 1mL/kg of normal saline. Group 2 received a single dose of 20 mg/kg of MTX intraperitoneally (IP) for 5 days. Group 3 received a single IP dose of 20 mg/kg of MTX followed by an oral dose of 10 mg/kg of Valsartan for 5 days. At the end of the experiment, the levels of serum kidney biomarkers, inflammatory and oxidative stress markers were accessed. Furthermore, the effect of MTX on kidney tissue histology was examined. Results and discussion: Our results showed that MTX treatment increased the level of serum kidney and inflammatory biomarkers and decreased the level of antioxidants SOD and GSH while increasing the lipid peroxidation contents. Furthermore, MTX treatment caused structural changes to kidney histology. However, the administration of Val significantly prevented these changes.

Conclusion

Valsartan possesses nephroprotective potential and might serve as a potential therapeutic strategy against MTX-induced kidney injury.

Schlagwörter

Stichwörter der Autor:innen

acute kidney injuryinflammationmethotrexateoxidative stressrenal toxicityrenoprotection

Autor:innen und Institutionen

  • Department of Pharmacy, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia.
  • Department of Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Umm AL-Qura University, Makkah, Saudi Arabia.

ORCID-Profile: Riyadh S Almalki

Zitieren

APA

Kutbi, D., & Almalki, R. S. (2024). Valsartan Mitigates the Progression of Methotrexate-Induced Acute Kidney Injury in Rats via the Attenuation of Renal Inflammation and Oxidative Stress. Journal of Inflammation Research, Volume 17, 2233-2243. https://doi.org/10.2147/jir.s456610

Vancouver

Kutbi D, Almalki RS. Valsartan Mitigates the Progression of Methotrexate-Induced Acute Kidney Injury in Rats via the Attenuation of Renal Inflammation and Oxidative Stress. Journal of Inflammation Research. 2024;Volume 17:2233-2243. doi:10.2147/jir.s456610

BibTeX
@article{Kutbi2024,
  author = {Kutbi, Dina and Almalki, Riyadh S},
  title = {Valsartan Mitigates the Progression of Methotrexate-Induced Acute Kidney Injury in Rats via the Attenuation of Renal Inflammation and Oxidative Stress},
  journal = {Journal of Inflammation Research},
  year = {2024},
  volume = {Volume 17},
  pages = {2233--2243},
  doi = {10.2147/jir.s456610}
}
Kostenlos starten →